RiMO Therapeutics
Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce toxicity.
est. 2015
Orpro Therapeutics is the older company (2006 vs 2015).
Side-by-Side Comparison
| Metric | Orpro Therapeutics | RiMO Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2006 older | 2015 |
| Headquarters | ||
| Headquarters | San Diego, United States | Not tracked yet |
| Employees | ||
| Employees | 2 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Grant | Grant |
| Total Funding | ||
| Total Funding | $4.48M | $250.00K |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Preclinical-stage, Respiratory Diseases, Ophthalmology, Oncology, Cell-protective Biologic Drug Platform, Thioredoxin, Inflammation, Mucociliary Functions, Chemotherapy, Radiation, Obstructive Disorders, Retina Diseases, Cancer Therapy, Cystic Fibrosis | Oncology Drug Development, Cancer Treatment, Radiotherapy, Radiodynamic Therapy, Tumor Eradication, Non-toxic Therapies, Combination Therapies, Unmet Medical Needs, Patient Care Improvement, Checkpoint Blockade Inhibitors, Immunotherapy, University Of Chicago Research, Innovative Therapy, Toxicity Reduction, Therapeutic Modalities |
| Website | ||
| Website | orprotherapeutics.com | rimorx.com |
About Orpro Therapeutics
OrPro Therapeutics is a San Diego-based preclinical-stage biotechnology company established in 2006. The company, a Johnson & Johnson JLABS alumni, is dedicated to addressing unmet medical needs in acute and chronic respiratory, ophthalmology, and oncology fields. OrPro Therapeutics utilizes a cell-...
About RiMO Therapeutics
RiMO Therapeutics, Inc. (RiMO) is a biotechnology startup established in 2015 with a mission to revolutionize cancer treatment. The company's proprietary Radio-immuno Metal-Organic (RiMO) technology, developed at the University of Chicago, aims to improve patient outcomes and reduce toxicity in canc...
We will tell you when either one moves
BounceWatch watches Orpro Therapeutics and RiMO Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Orpro Therapeutics and RiMO Therapeutics — by email.
Frequently Asked Questions
Compare Orpro Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Orpro Therapeutics on 12 Sep 2024, and RiMO Therapeutics on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
